Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Kenvue (KVUE) Asset Writedowns and Impairment (2024 - 2025)

Kenvue has reported Asset Writedowns and Impairment over the past 2 years, most recently at $23.0 million for Q4 2025.

Quarterly Asset Writedowns and Impairment changed N/A to $23.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23.0 million through Dec 2025, down 95.67% year-over-year, with the annual reading at $23.0 million for FY2025, 96.02% down from the prior year.
Asset Writedowns and Impairment was $23.0 million for Q4 2025 at Kenvue, down from $463.0 million in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $463.0 million in Q2 2024 and troughed at $23.0 million in Q4 2025.